Literature DB >> 15008262

The beta-thalassemia mutation/haplotype distribution in the moroccan population.

Wafaâ Lemsaddek1, Isabel Picanço, Filomena Seuanes, Paulo Nogueira, Lahoucine Mahmal, Saâd Benchekroun, Mohammed Khattab, Leonor Osório-Almeida.   

Abstract

The present study compiles the results of our own research and of a prior study on beta-thalassemia (thal) in Morocco, comprising a total of 187 beta-thalassemic chromosomes. Six major mutations: (beta0) codon 39 (C --> T), (beta+) IVS-I-6 (T --> C), (beta0) frameshift codon (FSC) 6 (-A), (beta0) FSC 8 (-AA), (beta0) IVS-I-1 (G --> A) and (beta+) -29 (A --> G) account for 75.7% of the independent chromosomes studied. A regional predominance was observed (Gharb and West regions) for the (beta+) IVS-I-6 (T --> C) mutation. Despite an observed heterogeneity of molecular anomalies, a direct method of diagnosis of the prevalent mutations is feasible in this population. The distributions of mutations and haplotypes are in conformity with the geographical location of Morocco and the historical links with both the Mediterranean communities that have successively interspersed with the Berbers, the Phoenicians, the Carthaginians, the Romans, the Arabs, the population of the Iberian Peninsula and, to a lesser degree, the Vandals and the Byzantines and permanently, with the Sub-Saharan Africans. In the adult population, the levels of fetal hemoglobin (Hb) in heterozygotes vary from trace quantities to 2.38 g/dL of total Hb. With the exception of the (beta0) codon 39 (C --> T) nonsense mutation, no statistically significant correlation was found, neither between mutation and Hb F levels, nor gender and Hb F levels in heterozygotes. The genetic markers for Hb F increase, located within cis active sites such as the XmnI site at -158 bp of the Ggamma-globin gene and the AT(X)T(Y) repeat region at -540 bp of the beta-globin gene, were assessed. The polymorphism XmnI shows linkage disequilibrium with haplotypes III, IV and IX, as previously observed in the Algerian, Sicilian and Portuguese beta-thal populations. Contrary to what has previously been reported for a population of beta-thal carriers of European descent, this sample does not show a statistically significant correlation between Hb F levels and the presence of the genetic markers XmnI restriction site at -158 bp of the Ggamma-globin gene and AT(X)T(Y) alleles at 5' of the beta-globin gene.

Entities:  

Mesh:

Year:  2004        PMID: 15008262     DOI: 10.1081/hem-120028884

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  6 in total

1.  Contribution of β-globin cluster polymorphisms to raise fetal hemoglobin levels in normal adults.

Authors:  Latifa Jouini; Amina Bibi; Faida Ouali; Sondess Hadj Fredj; Fekria Ouennich; Hajer Siala; Taieb Messaoud; Slaheddine Fattoum
Journal:  Mol Biol Rep       Date:  2011-09-27       Impact factor: 2.316

2.  Epidemiological profile of common haemoglobinopathies in Arab countries.

Authors:  Hanan A Hamamy; Nasir A S Al-Allawi
Journal:  J Community Genet       Date:  2012-12-08

3.  The Moroccan human mutation database.

Authors:  Ilham Ratbi; Alae-Eddine Gati; Abdelaziz Sefiani
Journal:  Indian J Hum Genet       Date:  2008-09

4.  Understanding the contrasting spatial haplotype patterns of malaria-protective β-globin polymorphisms.

Authors:  Carinna Hockham; Frédéric B Piel; Sunetra Gupta; Bridget S Penman
Journal:  Infect Genet Evol       Date:  2015-09-21       Impact factor: 3.342

5.  Molecular heterogeneity of β-thalassemia variants in the Eastern region of Morocco.

Authors:  Ihab Belmokhtar; Saida Lhousni; Mounia Elidrissi Errahhali; Ayad Ghanam; Manal Elidrissi Errahhali; Zaina Sidqi; Meryem Ouarzane; Majida Charif; Mohammed Bellaoui; Redouane Boulouiz; Noufissa Benajiba
Journal:  Mol Genet Genomic Med       Date:  2022-05-26       Impact factor: 2.473

6.  Effect of Cis Acting Potential Regulators in the β Globin Gene Cluster on the Production of HbF in Thalassemia Patients.

Authors:  Pooja Dabke; Roshan Colah; Kanjaksha Ghosh; Anita Nadkarni
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-02-16       Impact factor: 2.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.